Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

1.15
-0.1200-9.45%
Post-market: 1.170.0200+1.74%19:52 EDT
Volume:355.36K
Turnover:432.18K
Market Cap:3.94M
PE:-0.17
High:1.30
Open:1.29
Low:1.15
Close:1.27
52wk High:30.30
52wk Low:1.09
Shares:3.43M
Float Shares:2.20M
Volume Ratio:1.19
T/O Rate:16.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6592
EPS(LYR):-7.1047
ROE:-228.31%
ROA:-73.88%
PB:0.33
PE(LYR):-0.16

Loading ...

Hubei Native Yuan Xinyi Awarded Major International Prize Worth Approximately 7 Million Yuan

Deep News
·
Aug 14

IceCure Highlights 5-Year ICE3 Breast Cancer Trial Showing 3.1% Recurrence Rate After Cryoablation

Reuters
·
Aug 13

Israel's MediWound Beats Q2 Revenue Estimates, Reaffirms 2026 Guidance

Reuters
·
Aug 13

Finland's Bioretec H1 Revenue Rises 12%, Loss Narrows

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

Icecure Medical Q2 EPS $(1.37) Beats $(1.40) Estimate, Sales $889.000K Miss $1.450M Estimate

Benzinga Earnings
·
Aug 12

Icecure Medical Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Israel's IceCure Medical H1 Revenue Rises on Higher System, Probe Sales

Reuters
·
Aug 12

IceCure Net Loss Widens to USD 8.78 Million in H1 FY26; Revenue Rises 45% to USD 1.82 Million

Reuters
·
Aug 12

Icecure Reports Its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-over-Year

THOMSON REUTERS
·
Aug 12

Icecure Medical H1 Revenue USD 1.8 Million

THOMSON REUTERS
·
Aug 12

Press Release: IceCure Reports Its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-over-Year

Dow Jones
·
Aug 12

IceCure Medical Announces Board Change and New Independent Director

TIPRANKS
·
Aug 12

IceCure Adds Adventist Health Glendale as Enrolling Site for ChoICE Breast Cancer Cryoablation Study

Reuters
·
Aug 06

IceCure Medical Schedules First-Half Financial and Operating Results Release, Conference Call

Reuters
·
Aug 05

Icecure: Sio Petitions Nccn to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance of Prosense®

THOMSON REUTERS
·
Jul 29

IceCure Launches ChoICE Post-marketing Study of ProSense Cryoablation for Low-risk Breast Cancer in US

Reuters
·
Jul 27

Chinese Mathematicians Achieve Fields Medal Breakthrough; Wang Hong and Deng Yu Both Win, Yau Shing-Tung Hopes They Will Return to Teach

Deep News
·
Jul 23

IceCure Medical expands U.S. commercial team for ProSense cryoablation

TIPRANKS
·
Jul 14

Icecure Medical Publishes Investor Presentation on Prosense Fda-cleared Cryoablation Treatment for Low-risk Breast Cancer

Reuters
·
Jul 12